Literature DB >> 21645640

Common symptoms and stressors among individuals with inflammatory bowel diseases.

Sunny Singh1, Andrea Blanchard, John R Walker, Lesley A Graff, Norine Miller, Charles N Bernstein.   

Abstract

BACKGROUND & AIMS: We evaluated symptoms and stressful life events over a 1-year period in a population-based sample of persons with inflammatory bowel disease (IBD).
METHODS: Participants from the University of Manitoba IBD Research Registry (n = 704) completed 5 surveys, given every 3 months for 1 year (552 completed all the surveys). Respondents were asked to indicate the specific gastrointestinal and other symptoms, if any, they had experienced in the previous 3-month period and to document any significant stressors experienced. The Manitoba IBD Index was used to categorize active versus inactive disease.
RESULTS: In any 3-month period, participants with Crohn's disease, compared with those with ulcerative colitis (UC), reported more diarrhea (63% vs 38%), fatigue (54% vs 33%), abdominal pain (47% vs 32%), aching joints (42% vs 29%), painful joints (24% vs 16%), fever or night sweats (24% vs 15%), nausea/vomiting (18% vs 7%), and reductions in appetite (19% vs 11%) (P < .001 for each symptom). Individuals with ulcerative colitis complained more of stool mucous or blood than those with Crohn's disease (27% vs 17%; P < .001). In periods of inactive disease, participants still experienced symptoms such as aching joints (17%), fatigue (15%), diarrhea (13%), or abdominal pain (9%). In any 3-month period, approximately 50% experienced some type of stress; family stress was the most commonly reported form, followed by work or school and financial stress.
CONCLUSIONS: Diarrhea and fatigue are the 2 most common symptoms of individuals with IBD. Those with inactive disease still report symptoms. Almost 50% of participants reported significant stress in any 3-month period, but the primary types were everyday life stressors more so than health-related stress.
Copyright © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21645640     DOI: 10.1016/j.cgh.2011.05.016

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  26 in total

Review 1.  Association between NCF4 rs4821544T/C polymorphism and inflammatory bowel disease risk in Caucasian: a meta-analysis.

Authors:  Peng-Bo Wu; Jin-Fen Dai; Qian Wang; Guo Zhang; Shi-Yun Tan; Ming Li; Hui-Lan Ye
Journal:  Inflamm Res       Date:  2015-08-20       Impact factor: 4.575

Review 2.  Crucial steps in the natural history of inflammatory bowel disease.

Authors:  Giovanni Latella; Claudio Papi
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

Review 3.  [Psychophysiology of visceral pain].

Authors:  B Horing; P Enck
Journal:  Schmerz       Date:  2014-06       Impact factor: 1.107

4.  Increased Burden of Psychiatric Disorders in Inflammatory Bowel Disease.

Authors:  Charles N Bernstein; Carol A Hitchon; Randy Walld; James M Bolton; Jitender Sareen; John R Walker; Lesley A Graff; Scott B Patten; Alexander Singer; Lisa M Lix; Renée El-Gabalawy; Alan Katz; John D Fisk; Ruth Ann Marrie
Journal:  Inflamm Bowel Dis       Date:  2019-01-10       Impact factor: 5.325

5.  The Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Inflammatory Bowel Disease.

Authors:  Charles N Bernstein; Lixia Zhang; Lisa M Lix; Lesley A Graff; John R Walker; John D Fisk; Scott B Patten; Carol A Hitchon; James M Bolton; Jitender Sareen; Renée El-Gabalawy; James Marriott; Ruth Ann Marrie
Journal:  Inflamm Bowel Dis       Date:  2018-08-16       Impact factor: 5.325

6.  Symptoms among emerging adults with inflammatory bowel disease: a descriptive study.

Authors:  Kendra Kamp; Sharon Dudley-Brown; Margaret Heitkemper; Gwen Wyatt; Barbara Given
Journal:  Res Nurs Health       Date:  2019-10-10       Impact factor: 2.228

Review 7.  Treatment of IBD: where we are and where we are going.

Authors:  Charles N Bernstein
Journal:  Am J Gastroenterol       Date:  2014-12-09       Impact factor: 10.864

8.  Evaluation of Gastrointestinal Patient Reported Outcomes Measurement Information System (GI-PROMIS) Symptom Scales in Subjects With Inflammatory Bowel Diseases.

Authors:  Bharati Kochar; Christopher F Martin; Michael D Kappelman; Brennan M Spiegel; Wenli Chen; Robert S Sandler; Millie D Long
Journal:  Am J Gastroenterol       Date:  2017-08-29       Impact factor: 10.864

9.  Detailed Multi-Dimensional Assessment of Fatigue in Inflammatory Bowel Disease.

Authors:  Kristina Aluzaite; Rashid Al-Mandhari; Hamish Osborne; Christine Ho; Merrilee Williams; Marie-Michelle Sullivan; Catherine E Hobbs; Michael Schultz
Journal:  Inflamm Intest Dis       Date:  2019-03-15

10.  The Impact of Psychiatric Comorbidity on Health Care Utilization in Inflammatory Bowel Disease: A Population-based Study.

Authors:  Charles N Bernstein; Carol A Hitchon; Randy Walld; James M Bolton; Lisa M Lix; Renée El-Gabalawy; Jitender Sareen; Alexander Singer; Alan Katz; James Marriott; John D Fisk; Scott B Patten; Ruth Ann Marrie
Journal:  Inflamm Bowel Dis       Date:  2021-08-19       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.